Tag Archives: Drug

Viewpoints: Weigh Health Risks Of Football And The Big Feast This Thanksgiving; Count The Ways Drug Reps Were Taught To Market Opioids

Opinion writers weigh in on these health topics and others. Stat: Concussions, Broken Bones, And More: A Week Of U.S. Football  News about concussions and other injuries to young football players appears with alarming frequency, as do reports of the long-term damage to NFL players.Young pro players are leaving the game for fear of permanent… Read More »

White House urgently ramps up push for drug cost legislation

Battling impeachment, White House presses for drug cost legislation with new urgency By RICARDO ALONSO-ZALDIVAR Associated Press November 17, 2019, 12:54 PM 1 min read The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. With the impeachment investigation advancing, domestic policy adviser Joe Grogan says… Read More »

FDA panel unanimously backs expanding use of Amarin’s heart drug Vascepa

(Reuters) – A panel of experts to the U.S. FDA recommended allowing Amarin Corp Plc’s fish-oil derived drug to be used as an add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease. The panel on Thursday voted 16-0 in favor of expanding approval, potentially opening up a… Read More »

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause

Weight gain after starting antiretroviral treatment probably has multiple causes but appears strongly linked to specific drugs, and to combinations of drugs, Dr Andrew Hill of the University of Liverpool told the 17th European AIDS Conference in Basel, Switzerland, on Thursday. He highlighted some of the problems with the ways in which the phenomenon has… Read More »

Vertex lands blockbuster triple combo nod for CF drug Trikafta—5 months early

The triple combo era in cystic fibrosis is here thanks to a Monday Vertex approval—and it’s here earlier than industry watchers expected. A lot earlier. Five months ahead of schedule—and just three months after the company submitted its regulatory application—the FDA green-lighted Trikafta for the treatment of CF patients over the age of 12 with… Read More »